Unusual 11 Mid-Day Movers 11/16: (GLBS) (DCIX) (SINO) Higher; (ELGX) (AKER) (PDLI) Lower
- Netflix, Inc. (NFLX) Tops Q4 EPS by 1c; Subs Beat Views
- S&P 500 ends up slightly with boost from financials; Netflix up late
- Nestle Said Examining Takeover of Mead Johnson (MJN) - Source
- La Quinta Holdings (LQ) Gains on Plan to Split in Two
- After-Hours Stock Movers 01/18: (OCLR) (CSX) (NFLX) Higher; (AMDA) (RCII) (ZYNE) Lower (more...)
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Diana Containerships Inc. (Nasdaq: DCIX) 180.9% HIGHER; see above.
Sino-Global Shipping (Nasdaq: SINO) 148.8% HIGHER; see above.
Seanergy Maritime (Nasdaq: SHIP) 46.8% HIGHER; see above.
StemCells (Nasdaq: STEM) 46.8% HIGHER; On November 11, 2016, StemCells, Inc., together with two of its wholly-owned subsidiaries, Stem Cell Sciences Holdings Limited and StemCells California, Inc., entered into an Asset Purchase Agreement with BOCO Silicon Valley, Inc., a California corporation and wholly-owned subsidiary of Bright Oceans Corporation. Pursuant to the terms and subject to the conditions set forth in the Asset Purchase Agreement, the Sellers will sell to BOCO US certain stem and progenitor cell lines that have been researched, studied or manufactured by the Company since 2007 (the "Cell Lines") and certain other tangible and intangible assets, including intellectual property and books and records, related to the foregoing (together with the Cell Lines, the "Assets") in exchange for $4,000,000 in cash, subject to a return of $100,000 to BOCO US if the sale of the Assets (the "Asset Sale") is not completed by December 1, 2016 (the "Asset Consideration"). $300,000 of the Asset Consideration was provided to the Company prior to November 11, 2016 in exchange for the Sellers’ agreement not to solicit or reach any agreement with any third party pertaining to the sale of the Assets.
Euroseas Ltd. (Nasdaq: ESEA) 33.7% HIGHER; see Seanergy above.
Endologix, Inc. (Nasdaq: ELGX) 23.2% LOWER; announced that the U.S Food and Drug Administration (FDA) has requested the Company provide 2-year patient follow-up data from the EVAS-FORWARD IDE Study of the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). The Company expects these data to be available and submitted to the FDA in the second quarter of 2017, followed by a possible FDA advisory panel meeting by the end of 2017, and potential FDA PMA approval of Nellix in the second quarter of 2018.
Akers Biosciences Inc. (AKER) 21.8% LOWER; continuing lower after closing down 9 percent on Tuesday.
PDL BioPharma, Inc. (Nasdaq: PDLI) 20.3% LOWER; announced that it intends to offer, subject to market and other conditions, $150 million aggregate principal amount of new convertible senior notes due December 1, 2021 (the Notes) under PDL's shelf registration statement filed with the U.S. Securities and Exchange Commission (SEC) on June 10, 2016 and declared effective by the SEC on June 28, 2016.
Eltek Ltd (Nasdaq: ELTK) 14.9% LOWER; reported Q3 EPS of ($0.04), versus $0.06 reported last year. Revenue for the quarter came in at $9.3 million, versus $10.8 million reported last year.
Invitae Corporation (NYSE: NVTA) 14.2% LOWER; announced that it has commenced an underwritten public offering of $40 million of shares of its common stock, before deducting underwriting discounts and commissions and other offering expenses. All of the shares are being offered by Invitae.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bill Barrett Corporation (BBG) Entered Confidentiality Agreement with Bonanza Creek Energy (BCEI) Pertaining to BCEI's Chapter 11 Proceeding
- UniPixel (UNXL) Reports MOU for Strategic Partnership with General Interface Solution
- Orthofix Int'l (OFIX) Confirms SEC Resolution
Create E-mail Alert Related CategoriesSpecial Reports
Related EntitiesUnusual 11 Mid-Day Movers
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!